99 related articles for article (PubMed ID: 2943545)
1. Modulation of lymphocyte responsiveness to phytohemagglutinin by micromolecular fibrinogen degradation products.
Janus TJ; Braun DP; Harris JE
Clin Immunol Immunopathol; 1986 Oct; 41(1):26-34. PubMed ID: 2943545
[TBL] [Abstract][Full Text] [Related]
2. Relationship of leukocyte numbers, immunoregulatory cell function, and phytohemagglutinin responsiveness in cancer patients.
Braun DP; Harris JE
J Natl Cancer Inst; 1981 Oct; 67(4):809-14. PubMed ID: 6974273
[TBL] [Abstract][Full Text] [Related]
3. Immunoregulatory cell function in peripheral blood leukocytes of patients with intracranial gliomas.
Braun DP; Penn RD; Flannery AM; Harris JE
Neurosurgery; 1982 Feb; 10(2):203-9. PubMed ID: 6280097
[TBL] [Abstract][Full Text] [Related]
4. Relationship of arachidonic acid metabolism to indomethacin-sensitive immunoregulatory function and lymphocyte PGE sensitivity in peripheral blood mononuclear cells of disseminated solid tumor cancer patients.
Braum DP; Harris JE; Rubenstein M
J Immunopharmacol; 1984; 6(3):227-36. PubMed ID: 6436387
[TBL] [Abstract][Full Text] [Related]
5. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
Victorino RM
J Clin Lab Immunol; 1983 Aug; 11(4):197-201. PubMed ID: 6230454
[TBL] [Abstract][Full Text] [Related]
6. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
Braun DP; Harris JE
J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism.
Santoli D; Zurier RB
J Immunol; 1989 Aug; 143(4):1303-9. PubMed ID: 2545787
[TBL] [Abstract][Full Text] [Related]
8. Aspirin-like drugs prime human T cells. Modulation of intracellular calcium concentrations.
Flescher E; Fossum D; Gray PJ; Fernandes G; Harper MJ; Talal N
J Immunol; 1991 Apr; 146(8):2553-9. PubMed ID: 1901879
[TBL] [Abstract][Full Text] [Related]
9. Modulation of polymorphonuclear leukocyte microbicidal activity and oxidative metabolism by fibrinogen degradation products D and E.
Kazura JW; Wenger JD; Salata RA; Budzynski AZ; Goldsmith GH
J Clin Invest; 1989 Jun; 83(6):1916-24. PubMed ID: 2542377
[TBL] [Abstract][Full Text] [Related]
10. Contribution of monocytes to the decreased lymphoproliferative response to phytohemagglutinin in patients with lung cancer.
Fariñas MC; Rodriguez-Valverde V; Zarrabeitia MT; Parra-Blanco JA; Sanz-Ortiz J
Cancer; 1991 Sep; 68(6):1279-84. PubMed ID: 1873782
[TBL] [Abstract][Full Text] [Related]
11. A novel arachidonic acid metabolite with stimulatory effect on PHA-induced mitogenesis of lymphocytes.
Johnsen SA; Green K; Papadogiannakis N; Olding LB
Scand J Immunol; 1987 Apr; 25(4):425-8. PubMed ID: 3107119
[TBL] [Abstract][Full Text] [Related]
12. Formation of thromboxane B2 and hydroxyarachidonic acids in purified human lymphocytes in the presence and absence of PHA.
Parker CW; Stenson WF; Huber MG; Kelly JP
J Immunol; 1979 Apr; 122(4):1572-7. PubMed ID: 448099
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of suppression of the depressed lymphocyte response in lung cancer patients.
Alberola V; González-Molina A; Trenor A; San Martín B; Lluch A; Palau F; Marín J; García-Conde FJ
Allergol Immunopathol (Madr); 1985; 13(3):213-9. PubMed ID: 2931010
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.
Goodwin JS; Messner RP; Peake GT
J Clin Invest; 1978 Oct; 62(4):753-60. PubMed ID: 701474
[TBL] [Abstract][Full Text] [Related]
15. The effects of indomethacin on T lymphocyte stimulation.
Kingston AE; Ivanyi J; Kay JE
Immunol Lett; 1984; 8(6):301-5. PubMed ID: 6335488
[TBL] [Abstract][Full Text] [Related]
16. Cellular immunity in Q fever: modulation of responsiveness by a suppressor T cell-monocyte circuit.
Koster FT; Williams JC; Goodwin JS
J Immunol; 1985 Aug; 135(2):1067-72. PubMed ID: 2409135
[TBL] [Abstract][Full Text] [Related]
17. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
18. Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility.
Kleinhenz ME; Ellner JJ; Spagnuolo PJ; Daniel TM
J Clin Invest; 1981 Jul; 68(1):153-62. PubMed ID: 6972952
[TBL] [Abstract][Full Text] [Related]
19. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
Auer IO; Röder A; Fröhlich J
Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
[TBL] [Abstract][Full Text] [Related]
20. Effects of fibrinogen degradation fragments D and E on cell-mediated immunity.
Ferrara JJ; Kan C; Luterman A; Curreri PW
J Surg Res; 1989 Aug; 47(2):134-7. PubMed ID: 2755117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
